SB
Samsara BioCapital Portfolio holdings
AUM
$489M
This Quarter Return
-11.73%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$374M
AUM Growth
+$374M
(-5.4%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
15.41%
Top 10 Holdings %
Top 10 Hldgs %
64.84%
Holding
61
New
5
Increased
7
Reduced
14
Closed
5
Top Buys
| 1 |
Scholar Rock
SRRK
|
$23.4M |
| 2 |
Nkarta
NKTX
|
$10.3M |
| 3 |
Lyra Therapeutics
LYRA
|
$10M |
| 4 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$9.97M |
| 5 |
HilleVax
HLVX
|
$8.34M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$2.43M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
$2.21M |
| 3 |
Aclaris Therapeutics
ACRS
|
$1.37M |
| 4 |
Instil Bio
TIL
|
$941K |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$927K |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRON
51
DELISTED
Kronos Bio
KRON
| $284K | 0.08% |
78,131
| – | – |
|
52
KALA BIO
KALA
$105M
| $180K | 0.05% |
601,162
| – | – |
|
|
NGM
53
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $175K | 0.05% |
13,669
| – | – |
|
54
Astria Therapeutics
ATXS
$394M
| $75K | 0.02% |
25,000
| – | – |
|
55
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
| $37K | 0.01% |
+133,333
| New | +$37K |
|
56
Surrozen, Inc. Warrant
SRZNW
$71.9K
| $19K | 0.01% |
+99,999
| New | +$19K |
|
|
ODT
57
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-700,421
| Closed | -$925K |
|
58
VistaGen Therapeutics
VTGN
$113M
| – | – |
-488,632
| Closed | -$606K |
|
59
Rocket Pharmaceuticals
RCKT
$358M
| – | – |
-40,550
| Closed | -$643K |
|
60
BioNTech
BNTX
$24.1B
| – | – |
-4,031
| Closed | -$688K |
|
|
AMRN
61
Amarin Corp
AMRN
$311M
| – | – |
-25,000
| Closed | -$82K |
|